Hong-yu Zhang
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Mesenchymal stromal cells-derived small extracellular vesicles modulate DC function to suppress Th2 responses via IL-10 in patients with allergic rhinitis.
Journal: European journal of immunology
Published: July 11, 2021
Mesenchymal stem cells regulate type 2 innate lymphoid cells via regulatory T cells through ICOS-ICOSL interaction.
Journal: Stem cells (Dayton, Ohio)
Published: August 02, 2020
Sex differences in group 2 innate lymphoid cell-dominant allergic airway inflammation.
Journal: Molecular immunology
Published: December 23, 2019
Small extracellular vesicles derived from human MSCs prevent allergic airway inflammation via immunomodulation on pulmonary macrophages.
Journal: Cell death & disease
Published: December 18, 2019
Small extracellular vesicles derived from human mesenchymal stromal cells prevent group 2 innate lymphoid cell-dominant allergic airway inflammation through delivery of miR-146a-5p.
Journal: Journal of extracellular vesicles
Published: October 06, 2019
Effects of myeloid and plasmacytoid dendritic cells on ILC2s in patients with allergic rhinitis.
Journal: The Journal of allergy and clinical immunology
Published: January 09, 2019
Human iPSC-MSCs prevent steroid-resistant neutrophilic airway inflammation via modulating Th17 phenotypes.
Journal: Stem cell research & therapy
Published: February 06, 2018
The genes involved in asthma with the treatment of human embryonic stem cell-derived mesenchymal stem cells.
Journal: Molecular immunology
Published: November 17, 2017
Showing 1-8 of 8
Last Updated: 09/26/2026